Loading organizations...
Mitsui & Co. Global Investment, Inc. operates as a venture capital firm specializing in early-stage technology investments. It provides financial backing and strategic support to startups in biotech, digital health, agtech, foodtech, fintech, and climatech. Leveraging its global network and industry insights, the firm guides portfolio companies beyond mere capital to foster growth.
Mitsui & Co. Global Investment, Inc. was established in 2001 by the global conglomerate Mitsui & Co., Ltd. This initiative reflected the parent's strategic insight: fostering new technological advancements was crucial for future expansion. The firm serves as a conduit for the Mitsui group, integrating disruptive innovations from the startup ecosystem.
The firm supports entrepreneurs developing scientific breakthroughs and cutting-edge technologies. Mitsui & Co. Global Investment, Inc. identifies and nurtures promising ventures, assisting their global scale. Its vision cultivates a portfolio of companies contributing to significant technological progress and adapting to evolving global markets.
Key people at Mitsui & Co. Global Investment.
Mitsui & Co. Global Investment has more than 26 tracked investments across 21 companies. The latest tracked deal is $45.0M Series A in Ellipsis Health in June 2025.
Key people at Mitsui & Co. Global Investment.
Mitsui & Co. Global Investment (often styled Mitsui & Co. Global Investment, Inc. or Mitsui Global Investment) is an investment arm affiliated with the broader Mitsui group that focuses on venture, growth and private-equity investments worldwide, supporting entrepreneurs with capital and operational guidance across multiple sectors[1][3].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Limitations and sources